“Our study highlights the potential of epigenomic profiling from a simple blood draw to provide a real-time, non-invasive readout of PSMA expression that corresponds with treatment response," says ...
Kearney Urology Center has reported a 50% reduction in biopsies since adopting EpiSwitch® PSE, a new accurate blood test for prostate cancer. The reduction is down to the marked improvement offered by ...
The 2023 CUA guideline highlights the significance of specimen collection and timing in prostate cancer genetic testing. Practical strategies are provided to optimize genetic testing outcomes, ...
Nature Reviews Urology - The introduction of WHO standards for PSA assays is a step forward for improving the comparability of these tests. Our current clinical decision limits, however, were ...